PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Disopyramide - Arrhythmias
PAD Profile : Disopyramide - Arrhythmias
Brand Names Include :
Rythmodan
Traffic Light Status
Status 1 of 2.
Status :
Blue
Important
Formulations :
- Capsules
Important Information :
Specialist initiation and at least one month supply before transfer to primary care
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Comments :
No comments returned.
Documents :
Status 2 of 2.
Guidelines
No guidelines returned.
Other Drugs
- Amiodarone hydrochloride
- Flecainide acetate
- Propafenone hydrochloride
- Digoxin
- Sotalol hydrochloride
- Atenolol
- Mexiletine hydrochloride
- Bisoprolol fumarate
- Lidocaine
- Metoprolol tartrate
- Procainamide hydrochloride
- Propranolol hydrochloride
- Verapamil hydrochloride
Other Indications
No indications returned.
Additional Documents
No additional documents returned.
Committee Recommendations
Date
Committee Name
Narrative
07 August 2024
Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)
The Surrey Heartlands Area Prescribing Committee agreed the traffic light status of this drug and indication as part of the Joint Formulary review.
Associated BNF Codes
02. Cardiovascular System
02.03.02. Drugs for arrhythmias